Horie R - Search Results

1

In vitro and in vivo antitumor activity of the NF-kappaB inhibitor DHMEQ in the human T-cell leukemia virus type I-infected cell line, HUT-102.

Ohsugi T, Kumasaka T, Ishida A, Ishida T, Horie R, Watanabe T, Umezawa K, Yamaguchi K. Ohsugi T, et al. Among authors: horie r. Leuk Res. 2006 Jan;30(1):90-7. doi: 10.1016/j.leukres.2005.06.001. Epub 2005 Jul 5. Leuk Res. 2006. PMID: 16002138

2

Ligand-independent signaling by overexpressed CD30 drives NF-kappaB activation in Hodgkin-Reed-Sternberg cells.

Horie R, Watanabe T, Morishita Y, Ito K, Ishida T, Kanegae Y, Saito I, Higashihara M, Mori S, Kadin ME, Watanabe T. Horie R, et al. Oncogene. 2002 Apr 11;21(16):2493-503. doi: 10.1038/sj.onc.1205337. Oncogene. 2002. PMID: 11971184

3

Cytoplasmic aggregation of TRAF2 and TRAF5 proteins in the Hodgkin-Reed-Sternberg cells.

Horie R, Watanabe T, Ito K, Morisita Y, Watanabe M, Ishida T, Higashihara M, Kadin M, Watanabe T. Horie R, et al. Am J Pathol. 2002 May;160(5):1647-54. doi: 10.1016/S0002-9440(10)61112-1. Am J Pathol. 2002. PMID: 12000717 Free PMC article.

4

Hodgkin's lymphoma and CD30 signal transduction.

Horie R, Higashihara M, Watanabe T. Horie R, et al. Int J Hematol. 2003 Jan;77(1):37-47. doi: 10.1007/BF02982601. Int J Hematol. 2003. PMID: 12568298 Review.

5

AP-1 mediated relief of repressive activity of the CD30 promoter microsatellite in Hodgkin and Reed-Sternberg cells.

Watanabe M, Ogawa Y, Ito K, Higashihara M, Kadin ME, Abraham LJ, Watanabe T, Horie R. Watanabe M, et al. Among authors: horie r. Am J Pathol. 2003 Aug;163(2):633-41. doi: 10.1016/S0002-9440(10)63690-5. Am J Pathol. 2003. PMID: 12875982 Free PMC article.

6

Rapid tumor death model for evaluation of new therapeutic agents for adult T-cell leukemia.

Ohsugi T, Yamaguchi K, Kumasaka T, Ishida T, Horie R, Watanabe T, Sakio N, Fujimoto T, Sakamoto N, Urano T. Ohsugi T, et al. Among authors: horie r. Lab Invest. 2004 Feb;84(2):263-6. doi: 10.1038/labinvest.3700034. Lab Invest. 2004. PMID: 14688803 Free article.

7

The biological basis of Hodgkin's lymphoma.

Horie R, Watanabe T. Horie R, et al. Drug News Perspect. 2003 Dec;16(10):649-56. doi: 10.1358/dnp.2003.16.10.829295. Drug News Perspect. 2003. PMID: 14747844 Review.

8

The NPM-ALK oncoprotein abrogates CD30 signaling and constitutive NF-kappaB activation in anaplastic large cell lymphoma.

Horie R, Watanabe M, Ishida T, Koiwa T, Aizawa S, Itoh K, Higashihara M, Kadin ME, Watanabe T. Horie R, et al. Cancer Cell. 2004 Apr;5(4):353-64. doi: 10.1016/s1535-6108(04)00084-4. Cancer Cell. 2004. PMID: 15093542 Free article.

9

Prompt tumor formation and maintenance of constitutive NF-kappaB activity of multiple myeloma cells in NOD/SCID/gammacnull mice.

Dewan MZ, Watanabe M, Terashima K, Aoki M, Sata T, Honda M, Ito M, Yamaoka S, Watanabe T, Horie R, Yamamoto N. Dewan MZ, et al. Among authors: horie r. Cancer Sci. 2004 Jul;95(7):564-8. doi: 10.1111/j.1349-7006.2004.tb02487.x. Cancer Sci. 2004. PMID: 15245591 Free PMC article.

10

A novel NF-kappaB inhibitor DHMEQ selectively targets constitutive NF-kappaB activity and induces apoptosis of multiple myeloma cells in vitro and in vivo.

Watanabe M, Dewan MZ, Okamura T, Sasaki M, Itoh K, Higashihara M, Mizoguchi H, Honda M, Sata T, Watanabe T, Yamamoto N, Umezawa K, Horie R. Watanabe M, et al. Among authors: horie r. Int J Cancer. 2005 Mar 10;114(1):32-8. doi: 10.1002/ijc.20688. Int J Cancer. 2005. PMID: 15523684

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

348 results

Search Page

Filters